Publications by authors named "Mireia Dominguez Bastante"
Background: During follow-up, incisional hernias can reduce the quality of life of transplant recipients. The objective was to analyze the incidence of incisional hernia and risk factors to detect improvements.
Methods: Retrospective study of transplant recipients between 2002 and 2021.
Objectives: Determine the usefulness of [18F]-fluorodeoxyglucose positron emission tomography/computed tomography ( FDG-PET/CT) in the preoperative setting of colorectal cancer (CRC), assessing its impact on changes in management strategy.
Methods: Retrospective study of CRC patients who underwent preoperative FDG-PET/CT and CT staging scans in a single referral center. The agreement between FDG-PET/CT, contrast-enhanced CT, and colonoscopy for the surgical location was compared using the κ coefficient.
A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in surgical patients with severe sepsis admitted to the intensive care unit.
J Pineal Res
March 2023
To determine whether IV melatonin therapy improves redox status and inflammatory responses in surgical patients with severe sepsis, a unicenter, phase II double-blind, randomized, placebo-controlled trial was carried out. The study included patients with severe sepsis marked by infectious systemic inflammatory response syndrome (SIRS), associated with organ dysfunction, hypoperfusion or hypotension requiring surgical intervention. IV melatonin at a daily dose of 60 mg, which was dissolved in 500 ml of 5% dextrose serum, was continuously administered to the patients for over 30 min starting on the day of the diagnoses during a 5-day period.
View Article and Find Full Text PDFBackground: Liver transplant (LT) is the treatment of choice for patients diagnosed with hepatocellular carcinoma (HCC) within the Milan criteria. Its applicability is limited by the risk for recurrence and the impact on waiting lists. We aimed to describe our results in patients with LT due to HCC and to evaluate its long-term survival outcomes.
View Article and Find Full Text PDFArticle Synopsis
- Cholangiocarcinoma is a serious liver cancer with a low survival rate, and surgery is currently the only treatment option that can cure it.
- Liver transplantation (LT) is recognized as the best treatment for another type of liver cancer, hepatocellular carcinoma, but there's potential for LT to help patients with intrahepatic cholangiocarcinoma (iCC).
- Research from a center revealed a case of successful incidental LT in an iCC patient with a 10-year survival, suggesting that updates to LT criteria could improve treatment options as donor availability increases.